Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals

OBJECTIVE: Patients with compensated hepatitis B-related cirrhosis receiving antivirals are at the risk of hepatocellular carcinoma (HCC). This study aimed to develop and validate a nomogram for predicting the incidence of HCC in patients with hepatitis-B related cirrhosis. DESIGN: A total of 632 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ke, Li, Ping, Zhang, Qun, Zhang, Yi, Bi, Yufei, Zeng, Xuanwei, Wang, Xianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978349/
https://www.ncbi.nlm.nih.gov/pubmed/36874109
http://dx.doi.org/10.3389/fonc.2023.1128062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978349/
https://www.ncbi.nlm.nih.gov/pubmed/36874109
http://dx.doi.org/10.3389/fonc.2023.1128062

Ejemplares similares